• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症伴甲状旁腺激素升高:单中心回顾性研究。

Primary Aldosteronism with Parathyroid Hormone Elevation: A Single-center Retrospective Study.

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Japan.

Department of Health Promotion and Medicine of the Future, Kanazawa University, Japan.

出版信息

Intern Med. 2021;60(7):993-998. doi: 10.2169/internalmedicine.5282-20. Epub 2021 Apr 1.

DOI:10.2169/internalmedicine.5282-20
PMID:33790140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8079911/
Abstract

Objective Primary aldosteronism (PA) is a major cause of secondary hypertension. The association between PA and other hormone disorders is unclear. The present study aimed to evaluate whether the parathyroid hormone (PTH) value is associated with PA subtypes or specific treatments. Methods We enrolled 135 patients with PA who had their PTH value measured before undergoing a specific treatment. We evaluated whether PTH value is associated with PA subtypes or with specific treatments. The present study is a single-center retrospective study (2011-2018). Results Our study showed that, among the patients with PA, the proportion of those with PTH elevation was >30%. The PTH value was significantly correlated with both the basal plasma aldosterone concentration (PAC) and PAC after a captopril challenge test. However, the PTH value was not significantly different between the patients with unilateral and bilateral PA. We observed that the serum PTH value decreased after treatment of PA with unilateral adrenalectomy or mineralocorticoid receptor antagonists. Conclusion Our findings suggest that the PTH value in PA patients might be associated with the autonomous production of aldosterone. However, there was no correlation between the PTH value and PA subtypes in our study. Additionally, our study showed that targeted treatment for PA may lead to a decrease in the serum PTH levels. Hence, the PTH value could potentially be used as an index for measuring the suitability for PA treatment.

摘要

目的 原发性醛固酮增多症(PA)是继发性高血压的主要病因。PA 与其他激素紊乱之间的关系尚不清楚。本研究旨在评估甲状旁腺激素(PTH)值是否与 PA 亚型或特定治疗方法相关。

方法 我们纳入了 135 例 PA 患者,这些患者在接受特定治疗前测量了其 PTH 值。我们评估了 PTH 值是否与 PA 亚型或特定治疗方法相关。本研究为单中心回顾性研究(2011-2018 年)。

结果 我们的研究表明,在 PA 患者中,PTH 升高的比例>30%。PTH 值与基础血浆醛固酮浓度(PAC)和卡托普利激发试验后的 PAC 均显著相关。然而,单侧和双侧 PA 患者的 PTH 值无显著差异。我们观察到单侧肾上腺切除术或盐皮质激素受体拮抗剂治疗 PA 后,血清 PTH 值下降。

结论 我们的研究结果提示,PA 患者的 PTH 值可能与醛固酮的自主产生有关。然而,在本研究中,PTH 值与 PA 亚型之间没有相关性。此外,我们的研究表明,针对 PA 的靶向治疗可能会导致血清 PTH 水平降低。因此,PTH 值可能可作为衡量 PA 治疗适宜性的指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2dc/8079911/f15a68e4bf56/1349-7235-60-0993-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2dc/8079911/01f4b264db06/1349-7235-60-0993-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2dc/8079911/f62ca8d035ce/1349-7235-60-0993-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2dc/8079911/c85811a56a9a/1349-7235-60-0993-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2dc/8079911/f15a68e4bf56/1349-7235-60-0993-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2dc/8079911/01f4b264db06/1349-7235-60-0993-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2dc/8079911/f62ca8d035ce/1349-7235-60-0993-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2dc/8079911/c85811a56a9a/1349-7235-60-0993-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2dc/8079911/f15a68e4bf56/1349-7235-60-0993-g004.jpg

相似文献

1
Primary Aldosteronism with Parathyroid Hormone Elevation: A Single-center Retrospective Study.原发性醛固酮增多症伴甲状旁腺激素升高:单中心回顾性研究。
Intern Med. 2021;60(7):993-998. doi: 10.2169/internalmedicine.5282-20. Epub 2021 Apr 1.
2
Factors affecting parathyroid hormone levels in different types of primary aldosteronism.不同类型原发性醛固酮增多症中影响甲状旁腺激素水平的因素
Clin Endocrinol (Oxf). 2016 Aug;85(2):267-74. doi: 10.1111/cen.12981. Epub 2016 Feb 2.
3
Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels.单侧原发性醛固酮增多症患者的腹主动脉钙化更严重,且与醛固酮和甲状旁腺激素水平升高有关。
Hypertens Res. 2020 Dec;43(12):1413-1420. doi: 10.1038/s41440-020-0529-7. Epub 2020 Aug 7.
4
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.醛固酮和甲状旁腺激素的相互作用作为代谢和心血管疾病的介质。
Metabolism. 2014 Jan;63(1):20-31. doi: 10.1016/j.metabol.2013.08.016. Epub 2013 Oct 2.
5
PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.醛固酮和血管紧张素 II 通过甲状旁腺激素的调节作用在醛固酮增多症中被削弱,并通过肾上腺切除术得到挽救。
J Clin Endocrinol Metab. 2019 Sep 1;104(9):3726-3734. doi: 10.1210/jc.2019-00143.
6
Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.原发性醛固酮增多症中钙代谢和甲状旁腺功能的改变,以及螺内酯或手术切除醛固酮分泌腺瘤对其的逆转作用。
Am J Hypertens. 1995 Sep;8(9):884-93. doi: 10.1016/0895-7061(95)00182-O.
7
Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.原发性醛固酮增多症患者的甲状旁腺功能亢进症:来自 GECOH 研究的横断面和干预数据。
J Clin Endocrinol Metab. 2012 Jan;97(1):E75-9. doi: 10.1210/jc.2011-2183. Epub 2011 Oct 19.
8
Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism.轻度甲状旁腺功能亢进:原发性醛固酮增多症的一种新的可手术纠正特征。
J Hypertens. 2012 Feb;30(2):390-5. doi: 10.1097/HJH.0b013e32834f0451.
9
Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors.肾上腺皮质肿瘤患者中醛固酮与甲状旁腺激素水平的关系。
Endocr Pract. 2022 Jan;28(1):90-95. doi: 10.1016/j.eprac.2021.09.002. Epub 2021 Sep 8.
10
Bone health and aldosterone excess.骨骼健康与醛固酮过多症。
Osteoporos Int. 2013 Nov;24(11):2801-7. doi: 10.1007/s00198-013-2399-1. Epub 2013 May 22.

引用本文的文献

1
Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDO.原发性醛固酮增多症对钙磷稳态的影响。来自西班牙原发性醛固酮增多症(SPAIN-ALDO)的研究结果。
J Endocrinol Invest. 2025 Apr 19. doi: 10.1007/s40618-025-02563-y.
2
Bilateral or Unilateral Aldosterone Hypersecretion and Responsiveness to Therapy Are Associated with Differences in Calcium/Phosphate Homeostasis in Patients with Primary Aldosteronism.双侧或单侧醛固酮分泌过多及对治疗的反应与原发性醛固酮增多症患者钙/磷稳态的差异相关。
Intern Med. 2024 Oct 1;63(19):2605-2612. doi: 10.2169/internalmedicine.3116-23. Epub 2024 Feb 26.
3

本文引用的文献

1
Impact of aldosterone-producing cell clusters on diagnostic discrepancies in primary aldosteronism.醛固酮生成细胞团对原发性醛固酮增多症诊断差异的影响。
Oncotarget. 2018 May 25;9(40):26007-26018. doi: 10.18632/oncotarget.25418.
2
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.原发性醛固酮增多症患者中心血管疾病及其危险因素的流行情况:日本多中心研究。
Hypertension. 2018 Mar;71(3):530-537. doi: 10.1161/HYPERTENSIONAHA.117.10263. Epub 2018 Jan 22.
3
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.
Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk.
肾上腺肿瘤的跨学科研究:原发性醛固酮增多症相关矿物质代谢状态与骨质疏松性骨折风险的深入探讨。
Int J Mol Sci. 2023 Dec 11;24(24):17338. doi: 10.3390/ijms242417338.
4
Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis.原发性醛固酮增多症患者的骨与矿物质代谢:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2022 Oct 31;13:1027841. doi: 10.3389/fendo.2022.1027841. eCollection 2022.
5
Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach.血钙正常型原发性甲状旁腺功能亢进症:需要标准化的临床处理方法。
Endocrinol Metab (Seoul). 2021 Jun;36(3):525-535. doi: 10.3803/EnM.2021.1061. Epub 2021 Jun 1.
经医学治疗的原发性醛固酮增多症的心脏代谢结局和死亡率:一项回顾性队列研究。
Lancet Diabetes Endocrinol. 2018 Jan;6(1):51-59. doi: 10.1016/S2213-8587(17)30367-4. Epub 2017 Nov 9.
4
Factors affecting parathyroid hormone levels in different types of primary aldosteronism.不同类型原发性醛固酮增多症中影响甲状旁腺激素水平的因素
Clin Endocrinol (Oxf). 2016 Aug;85(2):267-74. doi: 10.1111/cen.12981. Epub 2016 Feb 2.
5
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).日本高血压学会高血压管理指南(JSH 2014)
Hypertens Res. 2014 Apr;37(4):253-390. doi: 10.1038/hr.2014.20.
6
Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.甲状旁腺功能亢进症有助于识别由于醛固酮腺瘤引起的原发性醛固酮增多症。
Hypertension. 2012 Aug;60(2):431-6. doi: 10.1161/HYPERTENSIONAHA.112.195891. Epub 2012 Jun 25.
7
Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.单侧醛固酮增多症经长期螺内酯治疗后自发缓解。
J Clin Endocrinol Metab. 2012 Apr;97(4):1109-13. doi: 10.1210/jc.2011-2563. Epub 2012 Feb 15.
8
Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.原发性醛固酮增多症患者的甲状旁腺功能亢进症:来自 GECOH 研究的横断面和干预数据。
J Clin Endocrinol Metab. 2012 Jan;97(1):E75-9. doi: 10.1210/jc.2011-2183. Epub 2011 Oct 19.
9
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.原发性醛固酮增多症诊断与治疗指南——日本内分泌学会 2009 年版。
Endocr J. 2011;58(9):711-21. doi: 10.1507/endocrj.ej11-0133. Epub 2011 Aug 9.
10
Primary hyperparathyroidism with concurrent primary aldosteronism.原发性甲状旁腺功能亢进合并原发性醛固酮增多症。
Hypertension. 2011 Sep;58(3):341-6. doi: 10.1161/HYPERTENSIONAHA.111.173948. Epub 2011 Aug 8.